SEC Filings
Doma Perpetual Sold 2,936,794 Pacira Shares And Now Reports Owning None
An amendment to Doma's Schedule 13D says the group fell below 5% of Pacira on October 8, with sales at $36.29 and $36.34 a share.
SEC Filings
An amendment to Doma's Schedule 13D says the group fell below 5% of Pacira on October 8, with sales at $36.29 and $36.34 a share.
SEC Filings
An 8-K amendment lets the price move if a customer dispute at VAC's Sumter plant costs value; the Chief Legal Officer is also leaving.
SEC Filings
The 10-Q shows a $0.9 million sales cut from tariff refunds, fully offset in cost of goods sold.
SEC Filings
An amended filing says the board put Bethany Logan Ropa and Robyn R. Werner on the Audit Committee after they joined as independent directors.
SEC Filings
The galvanizing company's 10-Q shows finance leases tied to a purchase obligation, even as net leverage improved to 1.3x.
SEC Filings
The Boston adviser and its manager, George McCabe, certify the shares are not held to influence control of Lantronix.
SEC Filings
Total debt reached $2,196.4 million at August 31, up from $256.8 million at May 31, with the largest short-dated piece coming from Kloeckner.
SEC Filings
An 8-K shows the genomics company signed agreements with three dealers to borrow short-term cash for general corporate purposes.
SEC Filings
A Vortex hole with visible gold led the company's October 13 release, and CEO Diane Garrett said follow-up drilling is already underway.
SEC Filings
The Swiss company amended its articles after canceling repurchased shares, leaving 156,147,653 registered shares outstanding.
SEC Filings
An 8-K filed Tuesday shows the new facility, led by JPMorgan Chase, completes the refinancing of Tenable's prior credit agreement.
SEC Filings
An 8-K shows the drugmaker drew the first loan tranche and declined a separate royalty sale, with $1 billion in options still open.